Does amiodarone inhibit T3 binding to solubilized nuclear receptors in vitro?
One of the proposed mechanisms of action of amiodarone is by interfering with T3-receptor interactions. However, reports in the literature on this matter are contradictory and, in an attempt to resolve these contradictions, the effects of amiodarone on T3 binding to solubilized nuclear receptors from rat liver were investigated. A drug concentration-related competitive inhibition of T3 binding occurred in the presence of considerable amiodarone precipitation. Measurement of the proportion of soluble amiodarone over the range where significant inhibition of T3 binding was observed, revealed that the soluble amiodarone decreased over this range. Since the amiodarone preparation was free of any contaminant, these findings suggested that a product generated from amiodarone during incubation was responsible for the inhibition. HPLC analysis of the soluble amiodarone fraction indicated that, during incubation, two substances were generated from the parent compound. However, only the concentration of one of the substances continually increased whereas the other decreased with increasing concentrations of amiodarone added to the samples. These findings suggest that the inhibition of T3 binding to solubilized nuclear receptors in the presence of amiodarone results from the generation of a specific product from the amiodarone under certain conditions during incubation.
Wilson
B D
BD
Department of Pharmacology, University of Stellenbosch Medical School, Tygerberg, South Africa.
D000638:Amiodarone / Q000494:pharmacology*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D008099:Liver / Q000166:cytology / Q000648:ultrastructure; D009685:Nuclear Envelope / Q000032:analysis / Q000648:ultrastructure; D051381:Rats; D011988:Receptors, Thyroid Hormone / Q000032:analysis / Q000378:metabolism*; D014284:Triiodothyronine / Q000378:metabolism*
D011988:Receptors, Thyroid Hormone; D014284:Triiodothyronine; D000638:Amiodarone